CETP inhibition: lessons from two decades of clinical trials

30 August 2024 (15:30 - 15:40)

Organised by:

Video

Sign in to view the resources

Slides

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

4 More presentations in this session

Presentation thumbnail

Introduction

Professor K. Ray (London, GB)

Presentation thumbnail

What do we know now that could have changed the history of CETP Inhibition? Genetics and biology

Professor J. Kastelein (Amsterdam, NL)

Presentation thumbnail

A novel CETP-inhibitor to target CV risk reduction: where could it fit in future lipid management?

Professor E. Michos (Baltimore, US)

Presentation thumbnail

Discussion

Professor K. Ray (London, GB) Professor G. Norata (Milan, IT)

Access the full session

Session thumbnail

Innovating the clinical management of LDL-c: exploring CETP as therapeutic target

The Event

Event poster

ESC Congress 2024

30 August 2024 15:30 CET

You may be interested in

Congress Session

Innovating the clinical management of LDL-c: exploring CETP as therapeutic target

Congress Session

Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?

Congress Presentation

Novel oral pathways in LDL-c lowering therapy: the new promise of oral CETP inhibitors

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources